Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study

Overview of attention for article published in BMC Health Services Research, August 2015

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 72 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,051 followers.

Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone… http://t.co/dcH5TdQNKu #breastcancer

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.